Login / Signup
Yomna M Elmorshedy
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Oxide Nanoparticles
Combination Therapy
Immune Response
Emergency Department
Top Venues
Nanomedicine (London, England)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Riham M Abdelgalil
,
Yomna M Elmorshedy
,
Kadria A Elkhodairy
,
Mohamed Teleb
,
Adnan A Bekhit
,
Sherine N Khattab
,
Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Nanomedicine (London, England)
(2023)
Riham M Abdelgalil
,
Yomna M Elmorshedy
,
Kadria A Elkhodairy
,
Mohamed Teleb
,
Adnan A Bekhit
,
Sherine N Khattab
,
Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Nanomedicine (London, England)
17 (22) (2023)
Riham M Abdelgalil
,
Yomna M Elmorshedy
,
Kadria A Elkhodairy
,
Mohamed Teleb
,
Adnan A Bekhit
,
Sherine N Khattab
,
Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Nanomedicine (London, England)
(2023)
Riham M Abdelgalil
,
Yomna M Elmorshedy
,
Kadria A Elkhodairy
,
Mohamed Teleb
,
Adnan A Bekhit
,
Sherine N Khattab
,
Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Nanomedicine (London, England)
17 (22) (2023)
Riham M Abdelgalil
,
Yomna M Elmorshedy
,
Kadria A Elkhodairy
,
Mohamed Teleb
,
Adnan A Bekhit
,
Sherine N Khattab
,
Ahmed O Elzoghby
Engineered nanomedicines for augmenting the efficacy of colorectal cancer immunotherapy.
Nanomedicine (London, England)
17 (22) (2023)